Clifford Chance advises Gilde Healthcare on financing the combined acquisition of Artinis and NIRx

Global law firm Clifford Chance has advised specialized healthcare investor Gilde Healthcare on financing the combined private equity investments in Artinis Medical Systems (Netherlands) and NIRx Medical Technologies (Germany/United States), both pioneers in functional Near-Infrared Spectroscopy (fNIRS) solutions, a differentiated neuroimaging technology. This dual transaction brings together two highly complementary companies, establishing a new global leader in fNIRS.

The investment via two parallel transactions was executed in a proprietary setting, leveraging Gilde’s own developed investment thesis, broad network and deep expertise in the research tools sector